Analyst Articles

With oil prices near $40 per barrel, some oil sand producers are barely scraping by while others are losing money for every barrel they produce. With no end in sight, some companies have been forced to take the necessary steps to weather the current environment.Baytex Energy Corp… Read More

GlaxoSmithKline (NYSE: GSK) will sell its over-the-counter business to Ireland-based Perrigo to fulfill its regulatory obligations following its $20 billion-plus asset swap with Novartis. The 10-product portfolio, known as GlaxoSmithKline Consumer Healthcare, generated sales of about $110 million in 2014.As GSK undergoes this transition to refocus its vaccines business, the… Read More